McLean Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
McLean Asset Management's AMGN Position: Q2 2026 in Review
McLean Asset Management reduced its Amgen (AMGN) stake by 2.7% in Q2 2026, selling an estimated $9.93K and leaving 1,064 shares worth $410K. The position accounts for 0.05% of the portfolio, ranked #122.
McLean Asset Management first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- McLean Asset Management held 1,064 shares of Amgen worth $410K as of Q2 2026.
- McLean Asset Management sold 29 Amgen shares in Q2 2026, an estimated $9.93K.
- Amgen made up 0.05% of McLean Asset Management's portfolio in Q2 2026, its #122 holding.
- McLean Asset Management first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
- 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on McLean Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.